Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Louisville, KY
NPI: 1154737724Primary Practice Location
UNIVERSITY OF LOUISVILLE HOSPITAL
530 S Jackson St, Louisville, KY
Primary Employer
Ulrf Oncology
uoflhealth.org
HQ Phone
Get M.D. Rohit's Phone Numberphone_androidMobile
Get M.D. Rohit's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
AR State Medical License
KY State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 114 | 303 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 65 | 188 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 60 | 60 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 57 | 144 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 42 | 43 |
A Review of the Clinical Subgroup Analyses From the RE-LY Trial.
Authors: Aref Rahman
Journal: Rev Cardiovasc Med
Seizure protein 6 controls glycosylation and trafficking of kainate receptor subunits GluK2 and GluK3.
Authors: Martina Pigoni, Hung-en Hsia, Jana Hartmann, Jasenka Rudan Njavro, Merav Shmueli, Stephan Müller, Gökhan Güner, Johanna Tüshaus, Peer-hendrik Kuhn, Rohit Kumar, Pan Gao, Mai Tran, Bulat Ramazanov, Birgit Blank, Agnes Hipgrave Ederveen, Julia Von Blume, Christophe Mulle, Jenny Gunnersen, Manfred Wuhrer, Gerhard Rammes, Marc Busche, Thomas Koeglsperger, Stefan Lichtenthaler
Publication Date: 2019-09-14
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, DRUG: Cisplatin, OTHER: Quality-of-Life Assessment, RADIATION: Radiation Therapy, OTHER: Survey Administration, DRUG: Atezolizumab, DRUG: Gemcitabine, DRUG: Fluorouracil, PROCEDURE: Computed Tomography, DRUG: Mitomycin, PROCEDURE: Transurethral Resection of Bladder Tumor, PROCEDURE: Biopsy of Bladder, PROCEDURE: Cystoscopy
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: RADIATION: Radiation Therapy, DRUG: Navtemadlin, PROCEDURE: Surgical Procedure
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Abemaciclib, DRUG: Placebo for Abemaciclib, DRUG: Abiraterone, DRUG: Prednisone or Prednisolone
